World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
87
Citations
27564
World Ranking
2828
National Ranking
207

Barbara Seliger publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Barbara Seliger sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 595 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Barbara Seliger D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Barbara Seliger sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 87 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Barbara Seliger is affiliated with Martin Luther University Halle-Wittenberg in Germany. Their research spans several scientific fields, primarily focusing on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Seliger's work reflects a strong interdisciplinary approach, contributing to both basic and applied biomedical sciences.

Their publication record includes significant contributions to subfields such as immunology, oncology, molecular biology, cancer research, and pulmonary and respiratory medicine. This broad set of subfields underscores a comprehensive engagement with both fundamental immune system mechanisms and their implications in cancer and other diseases.

Seliger's main research topics include cancer immunotherapy and biomarkers, immune cell function and interaction, immunotherapy and immune responses, cancer genomics and diagnostics, CAR-T cell therapy research, microRNA in disease regulation, and aspects of the reproductive system and pregnancy.

Key recent publications illustrate the diversity and depth of Seliger's research interests:

  • What turns CREB on? And off? And why does it matter? (2020, Cellular and Molecular Life Sciences)
  • Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (2020, Nature Communications)
  • Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity (2020, Journal for ImmunoTherapy of Cancer)
  • "UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells (2020, Scientific Reports)
  • Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies (2021, Cancers)

Throughout their career, Seliger has collaborated extensively with other researchers. Frequent coauthors include Claudia Wickenhauser, Chiara Massa, Marcus Bauer, Christoforos Vaxevanis, and Karthikeyan Subbarayan. These collaborations have contributed to a diversified research portfolio and enhanced interdisciplinary linkages.

Seliger has published predominantly in a set of recurrent scientific journals and venues, highlighting their ongoing engagement with peer communities in immunology and oncology. Frequent publication outlets include Frontiers in Immunology, Cancers, OncoImmunology, Preprints.org, and Journal for ImmunoTherapy of Cancer.

Best Publications

  • LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

    Almut Brand;Katrin Singer;Gudrun E. Koehl;Marlene Kolitzus

  • Antigen-processing machinery breakdown and tumor growth.

    Barbara Seliger;Markus J Maeurer;Soldano Ferrone

  • Hydrogen peroxide – production, fate and role in redox signaling of tumor cells

    Claudia Lennicke;Jette Rahn;Rudolf Lichtenfels;Ludger A. Wessjohann

  • Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.

    Leisha A. Emens;Paolo A. Ascierto;Phillip K. Darcy;Sandra Demaria

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes

    T Wölfel;A Van Pel;V Brichard;J Schneider

  • Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.

    Andreas Hombach;Anja Wieczarkowiecz;Thomas Marquardt;Claudia Heuser

  • Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome

    Markus Meissner;Torsten E. Reichert;Martin Kunkel;William Gooding

  • HLA class I antigen abnormalities and immune escape by malignant cells.

    Barbara Seliger;Teresa Cabrera;Federico Garrido;Soldano Ferrone

  • TAP off — tumors on

    Barbara Seliger;Barbara Seliger;Markus J. Maeurer;Markus J. Maeurer;Soldano Ferrone;Soldano Ferrone

  • Tumors as elusive targets of T-cell-based active immunotherapy.

    Francesco M Marincola;Ena Wang;Meenhard Herlyn;Barbara Seliger

  • Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

    Yumeng Mao;Dhifaf Sarhan;André Steven;Barbara Seliger

  • Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines

    Aniruddha Choudhury;Jehad Charo;Sunil K. Parapuram;Richard C. Hunt

  • Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

    Barbara Seliger;Ursula Wollscheid;Frank Momburg;Thomas Blankenstein

  • Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.

    Barbara Seliger;Ulrike Ritz;Rupert Abele;Michaela Bock

  • NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis

    Ariella Glasner;Assi Levi;Jonatan Enk;Batya Isaacson

  • Immune signature of tumor infiltrating immune cells in renal cancer

    Katharina Geissler;Paolo Fornara;Christine Lautenschläger;Hans-Jürgen Holzhausen

  • 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

    Sandra Coral;Luca Sigalotti;Maresa Altomonte;Arne Engelsberg

  • Strategies of Tumor Immune Evasion

    Barbara Seliger

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

Frequent Co-Authors

Soldano Ferrone
Soldano Ferrone Harvard University
Alexander Knuth
Alexander Knuth University of Zurich
Robert Tampé
Robert Tampé Goethe University Frankfurt
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Frank Momburg
Frank Momburg German Cancer Research Center
Hinrich Abken
Hinrich Abken University of Regensburg
Christoph Huber
Christoph Huber BioNTech (Germany)
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Rolf Kiessling
Rolf Kiessling Karolinska Institute
Friedrich Lottspeich
Friedrich Lottspeich Max Planck Society

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open doors to several dynamic online healthcare degrees and career options. Many students interested in life sciences consider related health professions to diversify their skills and improve job prospects. For those seeking fast entry into the healthcare workforce, accelerated radiology tech programs online provide a streamlined path to become certified radiologic technologists, often with flexible study schedules.

Nutrition and diet are major focus areas within Biology. If you’re passionate about advancing nutrition science, dietetics masters programs online allow you to deepen expertise and qualify for diverse roles in clinical or community settings.

For students looking to build practical healthcare skills along with their science background, online medical assisting classes offer a fast, accessible route. These programs often come with financial aid and can equip you for versatile roles in patient care.

Already working as a medical assistant? Consider advancing further by enrolling in a medical assistant to lpn bridge program online. This pathway can help you achieve higher credentials and increase career opportunities in nursing.

Best Scientists Citing Barbara Seliger

Trending Scientists

Recently Published Articles